Kardigan, Inc. (KARD)
$14.67+3.31%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.3B
- Beta
- 6.05
- P/E (TTM)
- -6.30
- Short % float
- 8.85%
- Days to cover
- 3.8
- SI change
- +73.0%
- 1W
- -0.81%
- 1M
- -21.51%
- vs SPY 1W
- -1.97%
- vs SPY 1M
- -24.50%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on KARD?
- LOPJLB’s latest quantitative signal on Kardigan, Inc. (KARD) is SELL. Signals are updated daily.
- What market regime is KARD in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Kardigan, Inc. (KARD) do?
- Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its âCardiac Intelligenceâ platform to accelerate research and improve …